A recent study has indicated that vitamin D affects perineuronal nets within the brain, which could facilitate the loss of brain plasticity.
Scientists have identified novel genes associated with a specific form of schizophrenia, which could potentially aid diagnosis and development of treatments.
A novel study reveals that the placenta could play an imperative role in schizophrenia and possibly other neurodevelopmental disorders.
Efficacy and metabolic effects of lurasidone versus brexpiprazole in schizophrenia: a network meta-analysis
In this research article from Journal of Comparative Effectiveness Research, a new network meta-analysis compares lurasidone and brexpiprazole in acute schizophrenia.
In this research article from Personalized Medicine, explore how disorders such as depression and schizophrenia have been linked to specific neurotransmitter receptor variations.
Quality-adjusted life year difference in patients with predominant negative symptoms of schizophrenia treated with cariprazine and risperidone
In this research article from Journal of Comparative Effectiveness Research, learn how differing drug treatments influence the quality of life of schizophrenia patients.
Regions of the brain displaying increased responses to novel speech stimuli have been linked with the processing of social information and similarities drawn with schizophrenia and autism.
Research presented at SfN’s Neuroscience 2017 has highlighted novel applications of genetic and cellular techniques that may help us to better understand neurological disorders such as addiction and Zika.
Overturning previous thoughts on the disease’s localized disruptive effect on the brain; a new study has revealed a significantly larger scope of communications disruption caused by schizophrenia.
Genetic variant relating to protein involved in neurotransmission may affect brain’s ability to regulate emotion.